Rajal A Patel1, Derrick Lock2, Irene B Helenowski3, James P Chandler4, Sean Sachdev5, Matthew C Tate4, Tim J Kruser5. 1. Department of Radiation Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA. Electronic address: rajal.patel@northwestern.edu. 2. Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA. 3. Division of Biostatistics, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 4. Department of Neurological Surgery, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA. 5. Department of Radiation Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.
Abstract
BACKGROUND: Postoperative stereotactic radiosurgery (SRS) to the cavity after resection of brain metastases improves local control. We hypothesized that significant cavity constriction would occur from the immediate postoperative period to the time of SRS and aimed to elucidate optimal treatment timing. METHODS: We retrospectively reviewed 79 consecutive patients with 85 resection cavities treated with SRS after gross total resection of a brain metastasis. Preoperative lesion, immediate postoperative cavity, and cavity at the time of SRS were contoured for each patient. Factors influencing cavity size and interval cavity change were analyzed. RESULTS: Median immediate postoperative cavity volume was 7.5 cm3, and median SRS cavity volume was 8.7 cm3. Median time from surgery to SRS was 20 days. Median volumetric cavity change was an increase of 28%. Of cavities, 34 (40%) increased in size >2 cm3, whereas only 8 cavities (9%) decreased in size >2 cm3; 43 cavities (51%) had ≤2 cm3 change. The largest postoperative cavities experienced the smallest percentage cavity change in the time interval to SRS (Spearman correlation -0.32, P = 0.003). CONCLUSIONS: Cavity size after brain metastasis resection increased a median of 28% from immediate postoperative scan to time of SRS. Greater than 90% of postoperative cavities either increased >2 cm3 or remained within 2 cm3 of their immediate postoperative cavity volume. Early postoperative SRS within 2-3 weeks may be appropriate to minimize cavity growth. Delaying postoperative SRS beyond 3 weeks in hopes of significant cavity contraction is not warranted.
BACKGROUND: Postoperative stereotactic radiosurgery (SRS) to the cavity after resection of brain metastases improves local control. We hypothesized that significant cavity constriction would occur from the immediate postoperative period to the time of SRS and aimed to elucidate optimal treatment timing. METHODS: We retrospectively reviewed 79 consecutive patients with 85 resection cavities treated with SRS after gross total resection of a brain metastasis. Preoperative lesion, immediate postoperative cavity, and cavity at the time of SRS were contoured for each patient. Factors influencing cavity size and interval cavity change were analyzed. RESULTS: Median immediate postoperative cavity volume was 7.5 cm3, and median SRS cavity volume was 8.7 cm3. Median time from surgery to SRS was 20 days. Median volumetric cavity change was an increase of 28%. Of cavities, 34 (40%) increased in size >2 cm3, whereas only 8 cavities (9%) decreased in size >2 cm3; 43 cavities (51%) had ≤2 cm3 change. The largest postoperative cavities experienced the smallest percentage cavity change in the time interval to SRS (Spearman correlation -0.32, P = 0.003). CONCLUSIONS: Cavity size after brain metastasis resection increased a median of 28% from immediate postoperative scan to time of SRS. Greater than 90% of postoperative cavities either increased >2 cm3 or remained within 2 cm3 of their immediate postoperative cavity volume. Early postoperative SRS within 2-3 weeks may be appropriate to minimize cavity growth. Delaying postoperative SRS beyond 3 weeks in hopes of significant cavity contraction is not warranted.
Authors: Nasser K Yaghi; Stephanie Radu; Joseph G Nugent; David J Mazur-Hart; Brandi W Pang; Stephen G Bowden; Blair Murphy; Seunggu J Han Journal: Neurooncol Pract Date: 2022-02-02
Authors: Evan D Bander; Melissa Yuan; Anne S Reiner; Katherine S Panageas; Åse M Ballangrud; Cameron W Brennan; Kathryn Beal; Viviane Tabar; Nelson S Moss Journal: Neurooncol Pract Date: 2021-01-21
Authors: Eduardo M Marchan; Jennifer Peterson; Terence T Sio; Kaisorn L Chaichana; Anna C Harrell; Henry Ruiz-Garcia; Anita Mahajan; Paul D Brown; Daniel M Trifiletti Journal: Front Oncol Date: 2018-08-31 Impact factor: 6.244
Authors: David M Routman; Elizabeth Yan; Sujay Vora; Jennifer Peterson; Anita Mahajan; Kaisorn L Chaichana; Nadia Laack; Paul D Brown; Ian F Parney; Terry C Burns; Daniel M Trifiletti Journal: Front Neurol Date: 2018-11-13 Impact factor: 4.003
Authors: Samantha M Buszek; Karine A Al Feghali; Hesham Elhalawani; Neil Chevli; Pamela K Allen; Caroline Chung Journal: Sci Rep Date: 2020-03-18 Impact factor: 4.379